25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

GLAXOSMITHKLINE PHARMACEUTICALS LTD.
Buy, Hold or Sell?

Let's analyze GLAXOSMITHKLINE PHARMACEUTICALS LTD. together

I guess you are interested in GLAXOSMITHKLINE PHARMACEUTICALS LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of GLAXOSMITHKLINE PHARMACEUTICALS LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about GLAXOSMITHKLINE PHARMACEUTICALS LTD.

I send you an email if I find something interesting about GLAXOSMITHKLINE PHARMACEUTICALS LTD..

1. Quick Overview

1.1. Quick analysis of GLAXOSMITHKLINE PHARMACEUTICALS LTD. (30 sec.)










1.2. What can you expect buying and holding a share of GLAXOSMITHKLINE PHARMACEUTICALS LTD.? (30 sec.)

How much money do you get?

How much money do you get?
INR1.51
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR104.93
Expected worth in 1 year
INR113.52
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR136.46
Return On Investment
5.8%

For what price can you sell your share?

Current Price per Share
INR2,371.20
Expected price per share
INR1,932 - INR2,625
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of GLAXOSMITHKLINE PHARMACEUTICALS LTD. (5 min.)




Live pricePrice per Share (EOD)
INR2,371.20
Intrinsic Value Per Share
INR241.43 - INR530.95
Total Value Per Share
INR346.36 - INR635.88

2.2. Growth of GLAXOSMITHKLINE PHARMACEUTICALS LTD. (5 min.)




Is GLAXOSMITHKLINE PHARMACEUTICALS LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$209.7m$205.4m$4.2m2.0%

How much money is GLAXOSMITHKLINE PHARMACEUTICALS LTD. making?

Current yearPrevious yearGrowGrow %
Making money$69.6m$72m-$2.4m-3.5%
Net Profit Margin17.1%18.8%--

How much money comes from the company's main activities?

2.3. Financial Health of GLAXOSMITHKLINE PHARMACEUTICALS LTD. (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of GLAXOSMITHKLINE PHARMACEUTICALS LTD.?

Welcome investor! GLAXOSMITHKLINE PHARMACEUTICALS LTD.'s management wants to use your money to grow the business. In return you get a share of GLAXOSMITHKLINE PHARMACEUTICALS LTD..

First you should know what it really means to hold a share of GLAXOSMITHKLINE PHARMACEUTICALS LTD.. And how you can make/lose money.

Speculation

The Price per Share of GLAXOSMITHKLINE PHARMACEUTICALS LTD. is INR2,371. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of GLAXOSMITHKLINE PHARMACEUTICALS LTD..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in GLAXOSMITHKLINE PHARMACEUTICALS LTD., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR104.93. Based on the TTM, the Book Value Change Per Share is INR2.15 per quarter. Based on the YOY, the Book Value Change Per Share is INR-54.41 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR31.97 per quarter.
Based on historical numbers we can estimate the returns while holding a share of GLAXOSMITHKLINE PHARMACEUTICALS LTD..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.410.0%0.410.0%0.430.0%0.470.0%0.440.0%
Usd Book Value Change Per Share0.030.0%0.030.0%-0.640.0%-0.050.0%0.210.0%
Usd Dividend Per Share0.380.0%0.380.0%1.060.0%0.500.0%0.450.0%
Usd Total Gains Per Share0.400.0%0.400.0%0.420.0%0.450.0%0.660.0%
Usd Price Per Share22.93-22.93-15.62-17.97-17.53-
Price to Earnings Ratio55.80-55.80-36.73-80.72-75.51-
Price-to-Total Gains Ratio56.96-56.96-37.15-251.31-210.93-
Price to Book Ratio18.52-18.52-12.88-13.97-13.36-
Price-to-Total Gains Ratio56.96-56.96-37.15-251.31-210.93-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share27.98016
Number of shares35
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.380.50
Usd Book Value Change Per Share0.03-0.05
Usd Total Gains Per Share0.400.45
Gains per Quarter (35 shares)14.0915.74
Gains per Year (35 shares)56.3662.94
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
15344670-753
21067102140-14116
315811158210-21179
421114214280-28242
526418270350-35305
631721326420-42368
737025382490-49431
842328438560-57494
947532494630-64557
1052835550700-71620

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.00.0100.0%6.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%2.03.00.040.0%3.03.00.050.0%3.03.00.050.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.00.0100.0%6.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.00.0100.0%6.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of GLAXOSMITHKLINE PHARMACEUTICALS LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.1462.1460%-54.406+2635%-4.276+299%17.489-88%
Book Value Per Share--104.934104.9340%102.787+2%112.175-6%114.531-8%
Current Ratio--1.8351.8350%1.881-2%1.852-1%1.774+3%
Debt To Asset Ratio--0.5000.5000%0.477+5%0.468+7%0.465+7%
Debt To Equity Ratio--1.0011.0010%0.910+10%0.890+12%0.880+14%
Dividend Per Share--31.96931.9690%90.050-64%42.378-25%38.232-16%
Eps--34.82534.8250%36.049-3%39.511-12%37.308-7%
Free Cash Flow Per Share--32.51332.5130%25.984+25%31.113+4%26.991+20%
Free Cash Flow To Equity Per Share--32.51332.5130%25.984+25%11.664+179%7.258+348%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--530.947--------
Intrinsic Value_10Y_min--241.430--------
Intrinsic Value_1Y_max--38.832--------
Intrinsic Value_1Y_min--29.670--------
Intrinsic Value_3Y_max--127.628--------
Intrinsic Value_3Y_min--84.930--------
Intrinsic Value_5Y_max--229.630--------
Intrinsic Value_5Y_min--135.146--------
Market Cap401695507200.000+18%329172864665.400329172864665.4000%224318999921.100+47%258034188807.780+28%251728896222.300+31%
Net Profit Margin--0.1710.1710%0.188-9%0.203-16%0.193-11%
Operating Margin----0%-0%0.112-100%0.123-100%
Operating Ratio--1.1691.1690%1.168+0%1.217-4%1.228-5%
Pb Ratio22.597+18%18.51718.5170%12.882+44%13.969+33%13.356+39%
Pe Ratio68.088+18%55.79655.7960%36.732+52%80.723-31%75.509-26%
Price Per Share2371.200+18%1943.1001943.1000%1324.150+47%1523.170+28%1485.950+31%
Price To Free Cash Flow Ratio72.930+18%59.76359.7630%50.960+17%51.158+17%76.583-22%
Price To Total Gains Ratio69.506+18%56.95756.9570%37.150+53%251.313-77%210.934-73%
Quick Ratio--1.3211.3210%1.485-11%1.240+7%1.178+12%
Return On Assets--0.1660.1660%0.184-10%0.172-4%0.162+2%
Return On Equity--0.3320.3320%0.351-5%0.322+3%0.303+10%
Total Gains Per Share--34.11534.1150%35.644-4%38.102-10%55.721-39%
Usd Book Value--209761484.600209761484.6000%205471040.000+2%224236818.360-6%228947322.900-8%
Usd Book Value Change Per Share--0.0250.0250%-0.642+2635%-0.050+299%0.206-88%
Usd Book Value Per Share--1.2381.2380%1.213+2%1.324-6%1.351-8%
Usd Dividend Per Share--0.3770.3770%1.063-64%0.500-25%0.451-16%
Usd Eps--0.4110.4110%0.425-3%0.466-12%0.440-7%
Usd Free Cash Flow--64993692.00064993692.0000%51942420.000+25%62195232.320+4%53955262.033+20%
Usd Free Cash Flow Per Share--0.3840.3840%0.307+25%0.367+4%0.318+20%
Usd Free Cash Flow To Equity Per Share--0.3840.3840%0.307+25%0.138+179%0.086+348%
Usd Market Cap4740006984.960+18%3884239803.0523884239803.0520%2646964199.069+47%3044803427.932+28%2970400975.423+31%
Usd Price Per Share27.980+18%22.92922.9290%15.625+47%17.973+28%17.534+31%
Usd Profit--69615398.00069615398.0000%72061420.000-3%78982643.920-12%74578265.600-7%
Usd Revenue--406128954.400406128954.4000%383702960.000+6%386916404.440+5%383950006.767+6%
Usd Total Gains Per Share--0.4030.4030%0.421-4%0.450-10%0.658-39%
 EOD+4 -4MRQTTM+0 -0YOY+15 -195Y+15 -2010Y+16 -19

3.3 Fundamental Score

Let's check the fundamental score of GLAXOSMITHKLINE PHARMACEUTICALS LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1568.088
Price to Book Ratio (EOD)Between0-122.597
Net Profit Margin (MRQ)Greater than00.171
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.321
Current Ratio (MRQ)Greater than11.835
Debt to Asset Ratio (MRQ)Less than10.500
Debt to Equity Ratio (MRQ)Less than11.001
Return on Equity (MRQ)Greater than0.150.332
Return on Assets (MRQ)Greater than0.050.166
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of GLAXOSMITHKLINE PHARMACEUTICALS LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.819
Ma 20Greater thanMa 502,573.090
Ma 50Greater thanMa 1002,672.626
Ma 100Greater thanMa 2002,707.574
OpenGreater thanClose2,513.950
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About GLAXOSMITHKLINE PHARMACEUTICALS LTD.

GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. The company offers vaccines, such as Infanrix Hexa for vaccination of infants against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and disease caused by Haemophilus influenzae type B; Synflorix for active immunization of infants against pneumococcal diseases and acute otitis media; Havrix for active immunization against disease caused by Hepatitis A virus; Menveo to prevent invasive meningococcal disease; Boostrix for immunization against diphtheria, tetanus and pertussis; Fluarix Tetra for the prevention of influenza disease; Varilrix for active immunization against varicella; and Shingrix for prevention of herpes zoster and post-herpetic neuralgia. It also provides specialty medicines comprising NUCALA for severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome; and TRELEGY ELLIPTA for treating chronic obstructive pulmonary disease. In addition, the company offers general medicines, including AUGMENTIN and CEFTUM, which are antibiotics to treat bacterial infections; CALPOL for treatment of mild to moderate pain; ELTROXIN for hypothyroidism; CCM to treat calcium and vitamin D deficiency; NEOSPORIN for treatment and prevention of specific bacterial skin infections; BETNOVATE for skin conditions which require relief of inflammation; T-BACT for bacterial skin infections; and PHYSIOGEL for dry skin and dry skin associated with redness and itch. Further, it develops products for infectious diseases, HIV, oncology, and immunology. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. GlaxoSmithKline Pharmaceuticals Limited was incorporated in 1924 and is headquartered in Mumbai, India.

Fundamental data was last updated by Penke on 2024-11-16 07:34:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is overpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit GLAXOSMITHKLINE PHARMACEUTICALS LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare GLAXOSMITHKLINE PHARMACEUTICALS LTD. to the Drug Manufacturers - General industry mean.
  • A Net Profit Margin of 17.1% means that ₹0.17 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of GLAXOSMITHKLINE PHARMACEUTICALS LTD.:

  • The MRQ is 17.1%. The company is making a huge profit. +2
  • The TTM is 17.1%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ17.1%TTM17.1%0.0%
TTM17.1%YOY18.8%-1.6%
TTM17.1%5Y20.3%-3.2%
5Y20.3%10Y19.3%+1.0%
4.3.1.2. Return on Assets

Shows how efficient GLAXOSMITHKLINE PHARMACEUTICALS LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare GLAXOSMITHKLINE PHARMACEUTICALS LTD. to the Drug Manufacturers - General industry mean.
  • 16.6% Return on Assets means that GLAXOSMITHKLINE PHARMACEUTICALS LTD. generated ₹0.17 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of GLAXOSMITHKLINE PHARMACEUTICALS LTD.:

  • The MRQ is 16.6%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 16.6%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ16.6%TTM16.6%0.0%
TTM16.6%YOY18.4%-1.8%
TTM16.6%5Y17.2%-0.6%
5Y17.2%10Y16.2%+1.0%
4.3.1.3. Return on Equity

Shows how efficient GLAXOSMITHKLINE PHARMACEUTICALS LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare GLAXOSMITHKLINE PHARMACEUTICALS LTD. to the Drug Manufacturers - General industry mean.
  • 33.2% Return on Equity means GLAXOSMITHKLINE PHARMACEUTICALS LTD. generated ₹0.33 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of GLAXOSMITHKLINE PHARMACEUTICALS LTD.:

  • The MRQ is 33.2%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 33.2%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ33.2%TTM33.2%0.0%
TTM33.2%YOY35.1%-1.9%
TTM33.2%5Y32.2%+1.0%
5Y32.2%10Y30.3%+1.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of GLAXOSMITHKLINE PHARMACEUTICALS LTD..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient GLAXOSMITHKLINE PHARMACEUTICALS LTD. is operating .

  • Measures how much profit GLAXOSMITHKLINE PHARMACEUTICALS LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare GLAXOSMITHKLINE PHARMACEUTICALS LTD. to the Drug Manufacturers - General industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of GLAXOSMITHKLINE PHARMACEUTICALS LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y11.2%-11.2%
5Y11.2%10Y12.3%-1.1%
4.3.2.2. Operating Ratio

Measures how efficient GLAXOSMITHKLINE PHARMACEUTICALS LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • An Operation Ratio of 1.17 means that the operating costs are ₹1.17 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of GLAXOSMITHKLINE PHARMACEUTICALS LTD.:

  • The MRQ is 1.169. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.169. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.169TTM1.1690.000
TTM1.169YOY1.168+0.001
TTM1.1695Y1.217-0.048
5Y1.21710Y1.228-0.011
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of GLAXOSMITHKLINE PHARMACEUTICALS LTD..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if GLAXOSMITHKLINE PHARMACEUTICALS LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A Current Ratio of 1.84 means the company has ₹1.84 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of GLAXOSMITHKLINE PHARMACEUTICALS LTD.:

  • The MRQ is 1.835. The company is able to pay all its short-term debts. +1
  • The TTM is 1.835. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.835TTM1.8350.000
TTM1.835YOY1.881-0.045
TTM1.8355Y1.852-0.017
5Y1.85210Y1.774+0.078
4.4.3.2. Quick Ratio

Measures if GLAXOSMITHKLINE PHARMACEUTICALS LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare GLAXOSMITHKLINE PHARMACEUTICALS LTD. to the Drug Manufacturers - General industry mean.
  • A Quick Ratio of 1.32 means the company can pay off ₹1.32 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of GLAXOSMITHKLINE PHARMACEUTICALS LTD.:

  • The MRQ is 1.321. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.321. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.321TTM1.3210.000
TTM1.321YOY1.485-0.164
TTM1.3215Y1.240+0.081
5Y1.24010Y1.178+0.062
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of GLAXOSMITHKLINE PHARMACEUTICALS LTD..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of GLAXOSMITHKLINE PHARMACEUTICALS LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare GLAXOSMITHKLINE PHARMACEUTICALS LTD. to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.50 means that GLAXOSMITHKLINE PHARMACEUTICALS LTD. assets are financed with 50.0% credit (debt) and the remaining percentage (100% - 50.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of GLAXOSMITHKLINE PHARMACEUTICALS LTD.:

  • The MRQ is 0.500. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.500. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.500TTM0.5000.000
TTM0.500YOY0.477+0.024
TTM0.5005Y0.468+0.032
5Y0.46810Y0.465+0.003
4.5.4.2. Debt to Equity Ratio

Measures if GLAXOSMITHKLINE PHARMACEUTICALS LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare GLAXOSMITHKLINE PHARMACEUTICALS LTD. to the Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 100.1% means that company has ₹1.00 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of GLAXOSMITHKLINE PHARMACEUTICALS LTD.:

  • The MRQ is 1.001. The company is able to pay all its debts with equity. +1
  • The TTM is 1.001. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.001TTM1.0010.000
TTM1.001YOY0.910+0.090
TTM1.0015Y0.890+0.111
5Y0.89010Y0.880+0.010
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings GLAXOSMITHKLINE PHARMACEUTICALS LTD. generates.

  • Above 15 is considered overpriced but always compare GLAXOSMITHKLINE PHARMACEUTICALS LTD. to the Drug Manufacturers - General industry mean.
  • A PE ratio of 55.80 means the investor is paying ₹55.80 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of GLAXOSMITHKLINE PHARMACEUTICALS LTD.:

  • The EOD is 68.088. Based on the earnings, the company is expensive. -2
  • The MRQ is 55.796. Based on the earnings, the company is expensive. -2
  • The TTM is 55.796. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD68.088MRQ55.796+12.293
MRQ55.796TTM55.7960.000
TTM55.796YOY36.732+19.064
TTM55.7965Y80.723-24.927
5Y80.72310Y75.509+5.214
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of GLAXOSMITHKLINE PHARMACEUTICALS LTD.:

  • The EOD is 72.930. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 59.763. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 59.763. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD72.930MRQ59.763+13.167
MRQ59.763TTM59.7630.000
TTM59.763YOY50.960+8.804
TTM59.7635Y51.158+8.606
5Y51.15810Y76.583-25.425
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of GLAXOSMITHKLINE PHARMACEUTICALS LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 18.52 means the investor is paying ₹18.52 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of GLAXOSMITHKLINE PHARMACEUTICALS LTD.:

  • The EOD is 22.597. Based on the equity, the company is expensive. -2
  • The MRQ is 18.517. Based on the equity, the company is expensive. -2
  • The TTM is 18.517. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD22.597MRQ18.517+4.080
MRQ18.517TTM18.5170.000
TTM18.517YOY12.882+5.635
TTM18.5175Y13.969+4.549
5Y13.96910Y13.356+0.613
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets35,566,175
Total Liabilities17,789,778
Total Stockholder Equity17,776,397
 As reported
Total Liabilities 17,789,778
Total Stockholder Equity+ 17,776,397
Total Assets = 35,566,175

Assets

Total Assets35,566,175
Total Current Assets27,984,186
Long-term Assets7,581,989
Total Current Assets
Cash And Cash Equivalents 641,712
Short-term Investments 17,926,520
Net Receivables 2,220,571
Inventory 5,250,482
Other Current Assets 20,298
Total Current Assets  (as reported)27,984,186
Total Current Assets  (calculated)26,059,583
+/- 1,924,603
Long-term Assets
Property Plant Equipment 3,107,318
Intangible Assets 235,538
Long-term Assets Other 6,060
Long-term Assets  (as reported)7,581,989
Long-term Assets  (calculated)3,348,916
+/- 4,233,073

Liabilities & Shareholders' Equity

Total Current Liabilities15,249,461
Long-term Liabilities2,540,317
Total Stockholder Equity17,776,397
Total Current Liabilities
Accounts payable 6,254,097
Other Current Liabilities 17,727
Total Current Liabilities  (as reported)15,249,461
Total Current Liabilities  (calculated)6,271,824
+/- 8,977,637
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt186,650
Long-term Liabilities  (as reported)2,540,317
Long-term Liabilities  (calculated)186,650
+/- 2,353,667
Total Stockholder Equity
Retained Earnings 8,551,862
Total Stockholder Equity (as reported)17,776,397
Total Stockholder Equity (calculated)8,551,862
+/- 9,224,535
Other
Capital Stock1,694,060
Common Stock Shares Outstanding 169,406
Net Invested Capital 17,776,397
Net Working Capital 12,734,725
Property Plant and Equipment Gross 5,938,615



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
> Total Assets 
0
0
39,113,109
31,355,410
31,133,608
46,332,778
33,265,800
35,566,175
35,566,17533,265,80046,332,77831,133,60831,355,41039,113,10900
   > Total Current Assets 
16,742,459
21,864,082
20,094,620
17,748,814
22,026,398
37,080,323
24,942,600
27,984,186
27,984,18624,942,60037,080,32322,026,39817,748,81420,094,62021,864,08216,742,459
       Cash And Cash Equivalents 
0
0
987,766
1,048,115
4,051,892
2,861,871
349,400
641,712
641,712349,4002,861,8714,051,8921,048,115987,76600
       Short-term Investments 
0
0
10,490,145
9,570,145
7,320,145
26,165,395
17,769,300
17,926,520
17,926,52017,769,30026,165,3957,320,1459,570,14510,490,14500
       Net Receivables 
2,577,483
2,042,242
2,100,075
998,012
2,156,046
2,052,389
1,923,750
2,220,571
2,220,5711,923,7502,052,3892,156,046998,0122,100,0752,042,2422,577,483
       Inventory 
4,257,974
5,001,833
4,864,935
4,830,322
5,466,981
5,346,954
4,599,700
5,250,482
5,250,4824,599,7005,346,9545,466,9814,830,3224,864,9355,001,8334,257,974
       Other Current Assets 
1,037,446
2,012,237
1,540,397
878,186
2,630,994
517,621
1,676,900
20,298
20,2981,676,900517,6212,630,994878,1861,540,3972,012,2371,037,446
   > Long-term Assets 
0
0
19,051,760
13,606,596
9,107,065
9,252,247
8,323,200
7,581,989
7,581,9898,323,2009,252,2479,107,06513,606,59619,051,76000
       Property Plant Equipment 
8,259,263
11,730,238
13,670,968
8,270,867
3,541,241
3,254,472
3,151,200
3,107,318
3,107,3183,151,2003,254,4723,541,2418,270,86713,670,96811,730,2388,259,263
       Intangible Assets 
0
0
655,400
0
433,640
344,974
340,908
235,538
235,538340,908344,974433,6400655,40000
       Long-term Assets Other 
0
0
37,785
30,326
30,202
13,318
524,300
6,060
6,060524,30013,31830,20230,32637,78500
> Total Liabilities 
0
0
17,714,817
13,149,361
16,142,811
19,703,220
15,853,000
17,789,778
17,789,77815,853,00019,703,22016,142,81113,149,36117,714,81700
   > Total Current Liabilities 
7,202,325
15,998,637
14,543,195
10,219,501
13,545,807
16,984,288
13,263,600
15,249,461
15,249,46113,263,60016,984,28813,545,80710,219,50114,543,19515,998,6377,202,325
       Short Long Term Debt 
0
0
4,060
1,530
240
0
0
0
0002401,5304,06000
       Accounts payable 
2,789,273
5,058,552
4,058,148
3,570,602
4,661,299
5,705,487
4,277,900
6,254,097
6,254,0974,277,9005,705,4874,661,2993,570,6024,058,1485,058,5522,789,273
       Other Current Liabilities 
3,164,954
9,668,592
9,040,370
4,966,168
6,674,949
6,532,679
8,864,900
17,727
17,7278,864,9006,532,6796,674,9494,966,1689,040,3709,668,5923,164,954
   > Long-term Liabilities 
0
0
3,171,622
2,906,789
2,818,068
2,718,932
2,589,400
2,540,317
2,540,3172,589,4002,718,9322,818,0682,906,7893,171,62200
       Capital Lease Obligations Min Short Term Debt
0
0
0
416,630
346,026
200,765
155,400
186,650
186,650155,400200,765346,026416,630000
       Long-term Liabilities Other 
0
0
22,010
20,660
0
0
0
0
000020,66022,01000
> Total Stockholder Equity
0
0
21,398,292
18,206,049
14,990,797
26,629,558
17,412,800
17,776,397
17,776,39717,412,80026,629,55814,990,79718,206,04921,398,29200
   Common Stock
847,030
847,030
1,694,060
1,694,060
1,694,060
1,694,060
0
0
001,694,0601,694,0601,694,0601,694,060847,030847,030
   Retained Earnings Total Equity00000000
   Accumulated Other Comprehensive Income 00000000
   Capital Surplus 00000000
   Treasury Stock00000000
   Other Stockholders Equity 
10,576
66,446
11,508
-28,221
-256,902
-274,956
15,718,700
0
015,718,700-274,956-256,902-28,22111,50866,44610,576



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue34,417,708
Cost of Revenue-14,198,485
Gross Profit20,219,22320,219,223
 
Operating Income (+$)
Gross Profit20,219,223
Operating Expense-26,032,852
Operating Income8,384,856-5,813,629
 
Operating Expense (+$)
Research Development0
Selling General Administrative2,284,033
Selling And Marketing Expenses0
Operating Expense26,032,8522,284,033
 
Net Interest Income (+$)
Interest Income678,503
Interest Expense-17,987
Other Finance Cost-0
Net Interest Income660,516
 
Pretax Income (+$)
Operating Income8,384,856
Net Interest Income660,516
Other Non-Operating Income Expenses0
Income Before Tax (EBT)8,161,8798,384,856
EBIT - interestExpense = -17,987
5,899,610
5,917,597
Interest Expense17,987
Earnings Before Interest and Taxes (EBIT)08,179,866
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax8,161,879
Tax Provision-2,262,269
Net Income From Continuing Ops5,899,6105,899,610
Net Income5,899,610
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-660,516
 

Technical Analysis of GLAXOSMITHKLINE PHARMACEUTICALS LTD.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of GLAXOSMITHKLINE PHARMACEUTICALS LTD.. The general trend of GLAXOSMITHKLINE PHARMACEUTICALS LTD. is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine GLAXOSMITHKLINE PHARMACEUTICALS LTD.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of GLAXOSMITHKLINE PHARMACEUTICALS LTD..

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 2,514 < 2,575 < 2,625.

The bearish price targets are: 2,353 > 2,127 > 1,932.

Tweet this
GLAXOSMITHKLINE PHARMACEUTICALS LTD. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of GLAXOSMITHKLINE PHARMACEUTICALS LTD.. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

GLAXOSMITHKLINE PHARMACEUTICALS LTD. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of GLAXOSMITHKLINE PHARMACEUTICALS LTD.. The current macd is -74.22581246.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the GLAXOSMITHKLINE PHARMACEUTICALS LTD. price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for GLAXOSMITHKLINE PHARMACEUTICALS LTD.. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the GLAXOSMITHKLINE PHARMACEUTICALS LTD. price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
GLAXOSMITHKLINE PHARMACEUTICALS LTD. Daily Moving Average Convergence/Divergence (MACD) ChartGLAXOSMITHKLINE PHARMACEUTICALS LTD. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of GLAXOSMITHKLINE PHARMACEUTICALS LTD.. The current adx is 32.69.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell GLAXOSMITHKLINE PHARMACEUTICALS LTD. shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
GLAXOSMITHKLINE PHARMACEUTICALS LTD. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of GLAXOSMITHKLINE PHARMACEUTICALS LTD.. The current sar is 2,671.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
GLAXOSMITHKLINE PHARMACEUTICALS LTD. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of GLAXOSMITHKLINE PHARMACEUTICALS LTD.. The current rsi is 29.82. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
GLAXOSMITHKLINE PHARMACEUTICALS LTD. Daily Relative Strength Index (RSI) ChartGLAXOSMITHKLINE PHARMACEUTICALS LTD. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of GLAXOSMITHKLINE PHARMACEUTICALS LTD.. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the GLAXOSMITHKLINE PHARMACEUTICALS LTD. price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
GLAXOSMITHKLINE PHARMACEUTICALS LTD. Daily Stochastic Oscillator ChartGLAXOSMITHKLINE PHARMACEUTICALS LTD. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of GLAXOSMITHKLINE PHARMACEUTICALS LTD.. The current cci is -147.79382555.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
GLAXOSMITHKLINE PHARMACEUTICALS LTD. Daily Commodity Channel Index (CCI) ChartGLAXOSMITHKLINE PHARMACEUTICALS LTD. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of GLAXOSMITHKLINE PHARMACEUTICALS LTD.. The current cmo is -50.76804209.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
GLAXOSMITHKLINE PHARMACEUTICALS LTD. Daily Chande Momentum Oscillator (CMO) ChartGLAXOSMITHKLINE PHARMACEUTICALS LTD. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of GLAXOSMITHKLINE PHARMACEUTICALS LTD.. The current willr is -98.43037975.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
GLAXOSMITHKLINE PHARMACEUTICALS LTD. Daily Williams %R ChartGLAXOSMITHKLINE PHARMACEUTICALS LTD. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of GLAXOSMITHKLINE PHARMACEUTICALS LTD..

GLAXOSMITHKLINE PHARMACEUTICALS LTD. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of GLAXOSMITHKLINE PHARMACEUTICALS LTD.. The current atr is 89.25.

GLAXOSMITHKLINE PHARMACEUTICALS LTD. Daily Average True Range (ATR) ChartGLAXOSMITHKLINE PHARMACEUTICALS LTD. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of GLAXOSMITHKLINE PHARMACEUTICALS LTD.. The current obv is 633,977.

GLAXOSMITHKLINE PHARMACEUTICALS LTD. Daily On-Balance Volume (OBV) ChartGLAXOSMITHKLINE PHARMACEUTICALS LTD. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of GLAXOSMITHKLINE PHARMACEUTICALS LTD.. The current mfi is 30.94.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
GLAXOSMITHKLINE PHARMACEUTICALS LTD. Daily Money Flow Index (MFI) ChartGLAXOSMITHKLINE PHARMACEUTICALS LTD. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for GLAXOSMITHKLINE PHARMACEUTICALS LTD..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-29BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-30STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-01MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-08-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-08-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-10-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-31SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-13STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.

6.3. Candlestick Patterns

GLAXOSMITHKLINE PHARMACEUTICALS LTD. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of GLAXOSMITHKLINE PHARMACEUTICALS LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.819
Ma 20Greater thanMa 502,573.090
Ma 50Greater thanMa 1002,672.626
Ma 100Greater thanMa 2002,707.574
OpenGreater thanClose2,513.950
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of GLAXOSMITHKLINE PHARMACEUTICALS LTD. with someone you think should read this too:
  • Are you bullish or bearish on GLAXOSMITHKLINE PHARMACEUTICALS LTD.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about GLAXOSMITHKLINE PHARMACEUTICALS LTD.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about GLAXOSMITHKLINE PHARMACEUTICALS LTD.

I send you an email if I find something interesting about GLAXOSMITHKLINE PHARMACEUTICALS LTD..


Comments

How you think about this?

Leave a comment

Stay informed about GLAXOSMITHKLINE PHARMACEUTICALS LTD..

Receive notifications about GLAXOSMITHKLINE PHARMACEUTICALS LTD. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.